Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.

PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy. Treating patients with HER2-positive early breast cancer based on positron ...

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

AIIMS has secured two high-end machines, including a high energy linear accelerator (HELA) with 3D imaging and positron ...

Sara Gillooly says a part of her wishes that she had taken the opportunity to travel to Turkey for treatment instead of ...

PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...

Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...

August 29, 2006 — Whole-body positron emission tomography (PET) scans can help determine whether breast cancer has spread to the lymph nodes, US researchers report in the August issue of Archives of ...

Dr George Owiti, a radiographer at Kericho County Hospital examines the Chest CT results of a patient admitted to the hospital. [James Wanzala, Standard] Despite recent breakthroughs that have ...

The Foresight CLARITY test offers greater prognostic accuracy than PET/CT scans in large B-cell lymphoma by detecting ctDNA-MRD negativity, indicating better patient outcomes. ctDNA-MRD testing showed ...

Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT was superior to multiparametric MRI for primary locoregional staging of prostate cancer, according to results from a phase II ...

Shannon Orell-Bast knows that every day counts when it comes to a cancer diagnosis.